These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 16332920

  • 21. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM, Miettinen HM.
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [Abstract] [Full Text] [Related]

  • 22. Functional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene.
    Santos EL, Reis RI, Silva RG, Shimuta SI, Pecher C, Bascands JL, Schanstra JP, Oliveira L, Bader M, Paiva AC, Costa-Neto CM, Pesquero JB.
    Regul Pept; 2007 Jun 07; 141(1-3):159-67. PubMed ID: 17320985
    [Abstract] [Full Text] [Related]

  • 23. AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs.
    Seta K, Nanamori M, Modrall JG, Neubig RR, Sadoshima J.
    J Biol Chem; 2002 Mar 15; 277(11):9268-77. PubMed ID: 11777928
    [Abstract] [Full Text] [Related]

  • 24. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B, Beautrait A, Aguila B, Charles R, Escher E, Claing A, Bouvier M, Laporte SA.
    Sci Signal; 2012 Apr 24; 5(221):ra33. PubMed ID: 22534132
    [Abstract] [Full Text] [Related]

  • 25. Agonist-induced signaling, desensitization, and internalization of a phosphorylation-deficient AT1A angiotensin receptor.
    Olivares-Reyes JA, Smith RD, Hunyady L, Shah BH, Catt KJ.
    J Biol Chem; 2001 Oct 12; 276(41):37761-8. PubMed ID: 11495923
    [Abstract] [Full Text] [Related]

  • 26. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist.
    Lochard N, Thibault G, Silversides DW, Touyz RM, Reudelhuber TL.
    Circ Res; 2004 Jun 11; 94(11):1451-7. PubMed ID: 15117826
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.
    Ahn S, Shenoy SK, Wei H, Lefkowitz RJ.
    J Biol Chem; 2004 Aug 20; 279(34):35518-25. PubMed ID: 15205453
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
    Zhao Y, Chen X, Cai L, Yang Y, Sui G, Fu S.
    J Cell Physiol; 2010 Oct 20; 225(1):168-73. PubMed ID: 20458733
    [Abstract] [Full Text] [Related]

  • 30. Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells.
    Guimond MO, Wallinder C, Alterman M, Hallberg A, Gallo-Payet N.
    Eur J Pharmacol; 2013 Jan 15; 699(1-3):160-71. PubMed ID: 23211679
    [Abstract] [Full Text] [Related]

  • 31. Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2.
    Ahn S, Wei H, Garrison TR, Lefkowitz RJ.
    J Biol Chem; 2004 Feb 27; 279(9):7807-11. PubMed ID: 14711824
    [Abstract] [Full Text] [Related]

  • 32. Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT1 and AT2 receptors.
    Bkaily G, El-Bizri N, Nader M, Hazzouri KM, Riopel J, Jacques D, Regoli D, D'Orleans-Juste P, Gobeil F, Avedanian L.
    Peptides; 2005 Aug 27; 26(8):1418-26. PubMed ID: 15876474
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sarcosine1, glycine8 angiotensin II is a functional AT1 angiotensin receptor antagonist.
    Speth RC, Kim KH, Elton TS, Simasko S.
    Endocrine; 2005 Mar 27; 26(2):83-7. PubMed ID: 15888919
    [Abstract] [Full Text] [Related]

  • 35. AT1 receptor blocker-insensitive mutant AT1A angiotensin receptors reveal the presence of G protein-independent signaling in C9 cells.
    Szidonya L, Süpeki K, Karip E, Turu G, Várnai P, Clark AJ, Hunyady L.
    Biochem Pharmacol; 2007 May 15; 73(10):1582-92. PubMed ID: 17284329
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells.
    Le MT, De Backer JP, Hunyady L, Vanderheyden PM, Vauquelin G.
    Eur J Pharmacol; 2005 Apr 18; 513(1-2):35-45. PubMed ID: 15878707
    [Abstract] [Full Text] [Related]

  • 38. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.
    Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM, Lefkowitz RJ.
    Proc Natl Acad Sci U S A; 2003 Sep 16; 100(19):10782-7. PubMed ID: 12949261
    [Abstract] [Full Text] [Related]

  • 39. Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes.
    Rajagopal K, Whalen EJ, Violin JD, Stiber JA, Rosenberg PB, Premont RT, Coffman TM, Rockman HA, Lefkowitz RJ.
    Proc Natl Acad Sci U S A; 2006 Oct 31; 103(44):16284-9. PubMed ID: 17060617
    [Abstract] [Full Text] [Related]

  • 40. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    Aoki H, Richmond M, Izumo S, Sadoshima J.
    Biochem J; 2000 Apr 01; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.